Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The Endurant™ family of products provides the standard of care with a legacy of clinical success for the treatment of abdominal aortic aneurysm (AAA). Only the Endurant family of products, designed to address sac regression,1 has the deep clinical experience, favorable outcomes, and the most validated data on any single graft for everyday or extraordinary challenges. For the past five years, the Endurant II/IIs has been used in 1 out of 3 EVAR cases,1 with use in more than 450,000 patients worldwide.1
Contact UsEndurant IIs stent graft is a three-piece system that:
Accurate placement and controlled deployment. Flexible, kink-resistant delivery system facilitates stent graft delivery. Tip capture for precise positioning adjustments, including adjustment of placement proximally or distally.
Continuous seal, fixation, and graft conformability. M-shaped proximal stents provide wall apposition and circumferential conformability.
Durable hemostatic barrier and resistance against type II endoleaks. High density, multifilament polyester graft material provides lower porosity for resistance against type II endoleaks.
Deployment, capture, and release of the Endurant II stent.
All indications related to Endurant II/IIs Stent Graft System are not approved globally. Please check your local regulatory approval status. Refer to the complete Instructions for Use manual of the Endurant II/IIs stent graft system for the indications approved in your geography.
The Endurant II/IIs stent graft system is indicated for the endovascular treatment of infrarenal or juxtarenal abdominal aortic or aortoiliac aneurysms in patients with the following characteristics:
In addition, for treatment of infrarenal abdominal aortic or aortoiliac aneurysms, the following patient characteristics apply:
In addition, for treatment of juxtarenal abdominal aortic or aortoiliac aneurysms with the parallel graft technique,† the following patient characteristics apply:
Note: The angle between the aortic and renal artery blood lumen centerlines is the renal take-off angulation. An angle of < 90° is associated with a downward-pointed renal artery relative to the trajectory of the aortic centerline.
†These indications are not approved for use by FDA. Please refer to the brief statement for indications for use in the United States.
Find this technical manual in the Medtronic Manual Library, in the product labeling supplied with each device, or by calling 1-877-526-7890.
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETBF | 23 | 13 | C | 124 | EE | 18 |
ETBF | 23 | 13 | C | 145 | EE | 18 |
ETBF | 23 | 13 | C | 166 | EE | 18 |
ETBF | 23 | 16 | C | 124 | EE | 18 |
ETBF | 23 | 16 | C | 145 | EE | 18 |
ETBF | 23 | 16 | C | 166 | EE | 18 |
ETBF | 25 | 13 | C | 124 | EE | 18 |
ETBF | 25 | 13 | C | 145 | EE | 18 |
ETBF | 25 | 13 | C | 166 | EE | 18 |
ETBF | 25 | 16 | C | 124 | EE | 18 |
ETBF | 25 | 16 | C | 145 | EE | 18 |
ETBF | 25 | 16 | C | 166 | EE | 18 |
ETBF | 28 | 13 | C | 124 | EE | 18 |
ETBF | 28 | 13 | C | 145 | EE | 18 |
ETBF | 28 | 13 | C | 166 | EE | 18 |
ETBF | 28 | 16 | C | 124 | EE | 18 |
ETBF | 28 | 16 | C | 145 | EE | 18 |
ETBF | 28 | 16 | C | 166 | EE | 18 |
ETBF | 28 | 20 | C | 124 | EE | 18 |
ETBF | 28 | 20 | C | 145 | EE | 18 |
ETBF | 28 | 20 | C | 166 | EE | 18 |
ETBF | 32 | 16 | C | 124 | EE | 20 |
ETBF | 32 | 16 | C | 145 | EE | 20 |
ETBF | 32 | 16 | C | 166 | EE | 20 |
ETBF | 32 | 20 | C | 124 | EE | 20 |
ETBF | 32 | 20 | C | 145 | EE | 20 |
ETBF | 32 | 20 | C | 166 | EE | 20 |
ETBF | 36 | 16 | C | 145 | EE | 20 |
ETBF | 36 | 16 | C | 166 | EE | 20 |
ETBF | 36 | 20 | C | 145 | EE | 20 |
ETBF | 36 | 20 | C | 166 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ESBF | 23 | 14 | C | 103 | EE | 18 |
ESBF | 25 | 14 | C | 103 | EE | 18 |
ESBF | 28 | 14 | C | 103 | EE | 18 |
ESBF | 32 | 14 | C | 103 | EE | 20 |
ESBF | 36 | 14 | C | 103 | EE | 20 |
Distal Graft |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
Total Contralateral Covered Length with EII/EIIs Bifurcated§ |
Total Ipsilateral Covered Length with EIIs Bifurcated|| |
|
---|---|---|---|---|---|---|---|---|
ETLW | 16 | 10 | C | 82 | EE | 14 | 136 | 155 |
ETLW | 16 | 10 | C | 93 | EE | 14 | 147 | 166 |
ETLW | 16 | 10 | C | 124 | EE | 14 | 178 | 177–197 |
ETLW | 16 | 10 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 10 | C | 199 | EE | 16 | 253 | 252–272 |
ETLW | 16 | 13 | C | 82 | EE | 14 | 136 | 155 |
ETLW | 16 | 13 | C | 93 | EE | 14 | 147 | 166 |
ETLW | 16 | 13 | C | 124 | EE | 14 | 178 | 177–197 |
ETLW | 16 | 13 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 13 | C | 199 | EE | 16 | 253 | 252–272 |
ETLW | 16 | 16 | C | 82 | EE | 14 | 136 | 135–155 |
ETLW | 16 | 16 | C | 93 | EE | 14 | 147 | 146–166 |
ETLW | 16 | 16 | C | 124 | EE | 14 | 178 | 177–197 |
ETLW | 16 | 16 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 16 | C | 199 | EE | 16 | 253 | 252–272 |
ETLW | 16 | 20 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 20 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 20 | C | 124 | EE | 16 | 178 | 177–197 |
ETLW | 16 | 20 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 20 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 24 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 24 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 24 | C | 124 | EE | 16 | 178 | 177–197 |
ETLW | 16 | 24 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 24 | C | 199 | EE | 16 | 253 | 252–272 |
ETLW | 16 | 28 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 28 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 28 | C | 124 | EE | 16 | 178 | 177–197 |
ETLW | 16 | 28 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 28 | C | 199 | EE | 16 | 253 | 252–272 |
‡The limb mates with the AUI stent graft on the ipsilateral side.
§These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant
||The 3–5 stent overlap is available only with select limbs. Please refer to the Instructions for Use for more information.
Proximal |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETCF | 23 | 23 | C | 49 | EE | 18 |
ETCF | 25 | 25 | C | 49 | EE | 18 |
ETCF | 28 | 28 | C | 49 | EE | 18 |
ETCF | 32 | 32 | C | 49 | EE | 20 |
ETCF | 36 | 36 | C | 49 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETTF | 23 | 23 | C | 70 | EE | 18 |
ETTF | 25 | 25 | C | 70 | EE | 18 |
ETTF | 28 | 28 | C | 70 | EE | 18 |
ETTF | 32 | 32 | C | 70 | EE | 20 |
ETTF | 36 | 36 | C | 70 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETUF | 23 | 14 | C | 102 | EE | 18 |
ETUF | 25 | 14 | C | 102 | EE | 18 |
ETUF | 28 | 14 | C | 102 | EE | 18 |
ETUF | 32 | 14 | C | 102 | EE | 20 |
ETUF | 36 | 14 | C | 102 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETEW | 10 | 10 | C | 82 | EE | 14 |
ETEW | 13 | 13 | C | 82 | EE | 14 |
ETEW | 20 | 20 | C | 82 | EE | 16 |
ETEW | 24 | 24 | C | 82 | EE | 16 |
ETEW | 28 | 28 | C | 82 | EE | 18 |
Choose from a complete portfolio of market-leading aortic vascular therapies to treat aneurysm disease.
Download CatalogDelivery success = successful vascular access and delivery of the device to the intended anatomical treatment site. Deployment success = successful deployment of the device in the intended site and the successful removal of the delivery system. Endurant™ US IDE trial: Makaroun M. One-year outcomes of the U.S. regulatory trial of the Endurant™ stent graft system.
These indications are not approved for use by FDA. Please refer to the brief statement for indications for use in the United States.
The limb mates with the AUI stent graft on the ipsilateral side.
These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant II Stent Graft System Instructions for Use. When using the 124 mm length bifurcated stent graft, subtract 10 mm from Total Contralateral Covered Length with Bifurcated.
The 3–5 stent overlap is available only with select limbs. Please refer to the Instructions for Use for more information.
Data on file at Medtronic.
Bench test data on file at Medtronic. Bench test data may not be indicative of clinical performance.
Hekman KE, Wohlauer MV, Magee GA, et al. Current issues and future directions for vascular surgery training from the results of the 2016-2017 and 2017-2018 Association of Program Directors in Vascular Surgery annual training survey. J Vasc Surg. December 2019;70(6):2014-2020.